2025 Non-CME/CE Bonus Presentations
*Limited seating available. Please arrive promptly to ensure access to sessions.

Friday, October 3, 2025 | 9:20 AM – 10:30 AM

Clarity Across the Spectrum of Skin Types: Diagnosing and Treating AD in Skin of Color 
Speakers:  Andrew Alexis, MD and Jill Waibel, MD

Room: Gramercy
Sponsored by Lilly 

This is a Non-CME/CE Bonus Presentation

ZORYVE® (roflumilast): Discover a New Option in Topical Treatment 
Speakers:  Chesahna Kindred, MD, MBA, FAAD and Raj Chovatiya, MD, PhD, MSCI 

Room: Murray Hill
Sponsored by Arcutis 

This is a Non-CME/CE Bonus Presentation 


Friday, October 3, 2025 | 1:25 PM – 2:35 PM

OPZELURA in Practice: VITILIGO REAL-WORLD CASE STUDIES
Speaker:  Seemal Desai, MD 

Room: Gramercy
Sponsored by Incyte 

This is a Non-CME/CE Bonus Presentation 

Real People, Real Progress: Managing Moderate-to-Severe Atopic Dermatitis in Adults and Patients 12 and Up
Speaker:  Raj Chovatiya, MD, PhD, MSCI 

Room: Murray Hill
Sponsored by Pfizer 

This is a Non-CME/CE Bonus Presentation 


Saturday, October 4, 2025 | 9:05 AM – 10:15 AM

From Hacks to Healing with Vaseline: Science-backed, purpose-led 
Speaker:  Tiffany Yizar 

Room: Gramercy
Sponsored by Unilever 

This is a Non-CME/CE Bonus Presentation 

Vaseline unveils viral PJ hacks, highlights clinically proven VPJ benefits, introduces upgraded lotions with ceramide-boosting Ultra Hydrating Lipids™ and functional actives, plus a bold mobile medical unit initiative to expand essential care. 

Explore EBGLYSS® (lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression 
Speaker:  Mona Shahriari, MD 

Room: Murray Hill
Sponsored by Lilly 

This is a Non-CME/CE Bonus Presentation 

Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”, an event where a clinician will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and additional data across diverse patient populations. 


Saturday, October 4, 2025 | 12:55 PM – 2:05 PM

Clinical Case Discussion: A 62-Year-Old Female With Itchy Skin Lesions. Could It Be PN? 
Speaker: Karan Lal, DO, MS, FAAD 

Room: Gramercy
Sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. 

This is a Non-CME/CE Bonus Presentation 

Join us for a discussion-based program exploring a real-world case of a patient with extensive skin lesions and intense pruritus, her diagnostic and treatment journey, and a treatment option for her PN symptoms. 

Explore an Oral Treatment for Severe Alopecia Areata 
Speaker:  Mona Shahriari, MD 

Room: Murray Hill
Sponsored by Pfizer 

This is a Non-CME/CE Bonus Presentation 

Explore an Oral Treatment for Severe Alopecia Areata. Pfizer Inc. invites you to an engaging, non-CME, educational program presented by Dr. Mona Shahriari on the efficacy and safety of a FDA-approved treatment option 


Saturday, October 4, 2025 | 3:35 PM – 4:45 PM

Discover the Latest Chapter in the COSENTYX® (secukinumab) Story 
Speaker:  Ellen Menefee, DMSc, MPAS 

Room: Gramercy
Sponsored by Novartis 

This is a Non-CME/CE Bonus Presentation 

Ellen Menefee, DMSc, PA-C, will present clinical data on COSENTYX, including insights on patient challenges, clinical trial results, and the legacy of COSENTYX in the Novartis commitment to dermatology. 

BRIDGING GAPS IN DERMATOLOGY: THE PHYSICIANS COUNCIL FOR DIVERSITY, EQUITY, AND INCLUSION 4th Annual Symposium 
Speakers: Cheryl Burgess, MD, Porcia Love, MD, and Jane Yoo, MD 

Room: Murray Hill
Sponsored by SkinCeuticals PCDEI 

This is a Non-CME/CE Bonus Presentation 

The 4th annual PCDEI Symposium will highlight key learnings from the council’s recent initiative. Led by a panel of council members the session highlights progress, challenges, and opportunities to advance equitable dermatologic care for patients with skin of color. 


Sunday, October 5, 2025 | 9:20 AM – 10:30 AM

TREMFYA™ (guselkumab): Understanding the Unmet Needs For Undertreated Patients; Insights From The VISIBLE and SPECTREM Trials With TREMFYA® 
Speaker: Saakshi Khattri, MD

Room: Gramercy
Sponsored by Johnson & Johnson 

This is a Non-CME/CE Bonus Presentation 

Understanding the unmet needs in undertreated and underserved patients with moderate to severe plaque psoriasis (PsO), reviewing J&J’s commitment to treat all appropriate moderate to severe plaque PsO patients with TREMFYA® & helping all appropriate patients start and stay on TREMFYA® 

Exploring Skin Clearance from Head to Toe. 
Speaker:  Mona Shahriari, MD 

Room: Murray Hill
Sponsored by AbbVie 

This is a Non-CME/CE Bonus Presentation 


Sunday, October 5, 2025 | 12:55 PM – 2:05 PM

The Many Colors of Psoriasis: Presentation and impact across diverse populations 
Speaker:  James Song, MD 

Room: Gramercy
Sponsored by Amgen 

This is a Non-CME/CE Bonus Presentation 

Fast* Results, Real Progress: A New Treatment for Alopecia Areata 

*See efficacy results from 8 to 24 weeks of treatment 

Speaker: Jessica Mercer, MD 

A Lasting Treatment for the Patients You See Every Day 

An IL-23 Inhibitor for Moderate-to-Severe Plaque Psoriasis 

Speaker: Omar Noor, MD

Room: Murray Hill
Sponsored by Sun Pharma 

This is a Non-CME/CE Bonus Presentation